Julie Vincent Selected Research

Julie Vincent Research Topics

Disease

21	Neoplasms (Cancer) 04/2023 - 02/2010
13	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 04/2012
4	Glioblastoma (Glioblastoma Multiforme) 05/2024 - 10/2016
4	Neutropenia 12/2020 - 01/2013
4	Neoplasm Metastasis (Metastasis) 09/2019 - 03/2010
3	Cholangiocarcinoma 01/2023 - 01/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 07/2020 - 11/2016
3	Thrombocytopenia (Thrombopenia) 03/2019 - 01/2013
2	Adenocarcinoma 04/2023 - 05/2018
2	Disease Progression 01/2023 - 07/2020
2	COVID-19 01/2022 - 01/2021
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2019 - 02/2018
2	Tachycardia (Tachyarrhythmias) 01/2018 - 10/2016
2	Colonic Neoplasms (Colon Cancer) 02/2016 - 03/2010
2	Aortic Coarctation 10/2013 - 10/2010
2	Hypertension (High Blood Pressure) 10/2010 - 02/2010
1	Brain Neoplasms (Brain Tumor) 05/2024
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2022
1	Parkinson Disease (Parkinson's Disease) 11/2022
1	Thrombosis (Thrombus) 01/2021
1	Congenital Heart Defects (Congenital Heart Defect) 01/2021
1	Dihydropyrimidine Dehydrogenase Deficiency 11/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 08/2019
1	Hypersplenism (Anemia, Splenic) 03/2019
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2018
1	Splenomegaly 05/2018
1	Ventricular Tachycardia 01/2018
1	Syncope (Fainting) 11/2017
1	Atrial Fibrillation 10/2016
1	Diarrhea 12/2015
1	Microscopic Colitis 12/2015
1	Anemia 02/2014
1	Hypersensitivity (Allergy) 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2011

Drug/Important Bio-Agent (IBA)

13	Bevacizumab (Avastin)FDA Link 01/2023 - 04/2012
10	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 04/2010
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 03/2010
8	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 04/2012
6	Gemcitabine FDA Link 04/2023 - 03/2010
5	Leucovorin (Folinic Acid)FDA Link 01/2023 - 01/2014
5	folfirinoxIBA 12/2020 - 01/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 02/2016
3	Biomarkers (Surrogate Marker)IBA 05/2018 - 10/2016
2	AntibodiesIBA 01/2022 - 01/2021
2	Trastuzumab (Herceptin)FDA Link 08/2019 - 01/2011
2	afliberceptIBA 02/2019 - 12/2015
1	RNA (Ribonucleic Acid)IBA 04/2023
1	Proteins (Proteins, Gene)FDA Link 11/2022
1	SynucleinsIBA 11/2022
1	ErbB Receptors (EGF Receptor)IBA 10/2021
1	Monoclonal AntibodiesIBA 10/2021
1	cangrelorIBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2020
1	pegfilgrastim (Neulasta)FDA Link 12/2020
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 11/2020
1	Cisplatin (Platino)FDA LinkGeneric 07/2020
1	Capecitabine (Xeloda)FDA Link 07/2020
1	Docetaxel (Taxotere)FDA Link 07/2020
1	raltitrexed (D 1694)IBA 09/2019
1	EnbucrilateIBA 03/2019
1	CyanoacrylatesIBA 03/2019
1	sulfolaneIBA 03/2019
1	AnticoagulantsIBA 01/2018
1	Anti-Arrhythmia AgentsIBA 11/2017
1	Lomustine (CCNU)FDA Link 10/2016
1	Cetuximab (Erbitux)FDA Link 02/2016
1	Mesalamine (Mesalazine)FDA LinkGeneric 12/2015
1	Budesonide (Pulmicort)FDA LinkGeneric 12/2015
1	Angiogenesis InhibitorsIBA 05/2014
1	Coenzyme A (CoA)IBA 10/2013
1	PlatinumIBA 10/2013
1	Interleukin-6 (Interleukin 6)IBA 03/2012
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2011
1	Dichlorodiphenyldichloroethane (DDD)IBA 02/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2010
1	Amiloride (Midamor)FDA LinkGeneric 02/2010

Therapy/Procedure

23	Drug Therapy (Chemotherapy) 04/2023 - 03/2010
10	Therapeutics 07/2020 - 10/2010
4	Neoadjuvant Therapy 08/2019 - 01/2011
3	Chemoradiotherapy 05/2024 - 10/2016
2	Intravenous Infusions 01/2023 - 02/2015
2	Combination Drug Therapy (Combination Chemotherapy) 10/2021 - 07/2020
2	Stents 10/2013 - 10/2010
1	Immunotherapy 05/2024
1	Catheter Ablation 10/2016
1	Intra-Arterial Infusions 02/2015
1	Biological Therapy 04/2012